Advertisement

Topics

IATI-Biomed 2015 Company Profile

06:21 EST 15th December 2018 | BioPortfolio

For the 14th consecutive year, IATI-Biomed is the largest and leading meeting place for healthcare professionals from Israel with international colleagues and partners. As such, this world-class event presents an opportunity for global participants to experience Israel’s life science innovation and vibrant biomedical industry at its best. Previous successful conferences hosted over 6,000 industry players, scientists and engineers including more than 1,000 attendees from over 45 countries that participated in over 4,500 one-on-one meetings. Hundreds of Israeli life science companies will present and exhibit their products, services and technologies allowing for hands-on experience. For more information, please visit http://biomed.kenes-exhibitions.com/.


News Articles [217 Associated News Articles listed on BioPortfolio]

Q BioMed Acquires Cancer Pain Drug From GE Healthcare

NewsThe acquisition of Metastron gives Q BioMed ownership of the drug and related market authorizations in 22 countries.Contributed Author: 

Q BioMed and SRI Collaborate on Formulation and Preclinical Work on Autism

NewsThe collaborative agreement will include early clinical manufacturing of QBM-001 in support of Q BioMed's Autistic Spectrum Disorder drug development program.

Harbour BioMed gets rights to Glenmark's bispecific antibody

Glenmark Pharmaceuticals SA granted Harbour BioMed exclusive rights to develop and sell its bispecific antibody GBR1302 for solid tumors in Greater China. Harbour BioMed also retains a manufacturing o...

Harbour BioMed raises $85m to accelerate growth of therapeutic pipeline

Harbour BioMed is engaged in the discovery and development of therapeutics for oncology and immunological diseases. The financing round was led by GIC Private Limited, and participants included The p...

Q BioMed takes final step to gaining FDA approval to manufacture its spearhead drug

Q BioMed Inc (OTCQB: QBIO) CEO Denis Corin tells Proactive Investors the commercial-stage biotech is taking the final step in the approval process of its bone pain relief treatment, the "spearhead'"...

Orchestra BioMed secures $41m funding for cardiovascular product candidates

Orchestra BioMed will use the funding to support continued late-stage clinical development of its Virtue sirolimus-eluting balloon (SEB) to treat artery disease and BackBeat cardiac neuromodulation th...

Q BioMed’s Metastron acquisition ‘positive development,’ advances pipeline, says Brookline Capital Markets

Analyst Kumaraguru Raja says Q BioMed’s ownership of this non-opioid cancer pain drug will give it ‘immediate, established, and long-term revenue’

Deals this week: Harbour BioMed, Emergent BioSolutions, Sierra Oncology

Harbour BioMed has signed a collaboration agreement with Kelun-Biotech Biopharmaceutical to develop and commercialise A167, an anti-PD-L1 antibody indicated for...Read More... The post Deals this week...

PubMed Articles [543 Associated PubMed Articles listed on BioPortfolio]

Decline of adolescent smoking in Ireland 1995-2015: trend analysis and associated factors.

The study examines trends in smoking among Irish adolescents aged 15-16 years between 1995 and 2015 and the factors associated with their smoking behaviours between 2007 and 2015.

Neurologic manifestations in emerging arboviral diseases in Rio de Janeiro City, Brazil, 2015-2016.

Dengue has affected Rio de Janeiro City since the 1980s. The sequential Zika and chikungunya virus introductions during 2015 aggravated the health scenario, with 97,241 cases of arboviral diseases rep...

Chronic obstructive pulmonary disease deaths, disability-adjusted life years, and risk factors in Hubei province of mid-China, 1990-2015: the Global Burden of Disease Study 2015.

The trends of chronic obstructive pulmonary disease (COPD) mortality and prevalence from 1990 to 2015 in Hubei province of mid-China remain unknown. We used findings from the Global Burden of Disease ...

Conjugate vaccine serotypes persist as major causes of non-invasive pneumococcal pneumonia in Portugal despite declines in serotypes 3 and 19A (2012-2015).

Non-invasive pneumococcal pneumonia (NIPP) is a frequent cause of morbidity and mortality worldwide. The 13-valent pneumococcal conjugate vaccine (PCV13) was included in the national immunization prog...

Trends in Lumbar Fusion Procedure Rates and Associated Hospital Costs for Degenerative Spinal Diseases in the United States, 2004-2015.

Analysis of National Inpatient Sample (NIS), 2004-2015.

Clinical Trials [520 Associated Clinical Trials listed on BioPortfolio]

Amendment of rTSST-1 Variant Vaccine Phase 1 First-in-man Trail

Toxic Shock Syndrome (TSS) a severe condition with high morbidity and mortality results from the hosts overwhelming inflammatory response and cytokine storm. Staphylococcal superantigen to...

Immunogenicity and Safety of Fluzone® Quadrivalent, Southern Hemisphere 2015 Formulation (Intramuscular Route)

The aim of the study was to assess the immunogenicity and safety of Fluzone Quadrivalent influenza vaccine Southern Hemisphere (SH) 2015 formulation in participants aged 18 to 60 years as ...

Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults

The aim of the study is to evaluate the safety and immunogenicity of the 2015-2016 formulations of Fluzone Quadrivalent and Fluzone Intradermal Quadrivalent vaccines in adults 18 to < 65 y...

Pumps for Kids, Infants, and Neonates

PumpKIN is a randomized, multicenter, two-arm trial evaluating the investigational Infant Jarvik 2015 versus the EXCOR® Pediatric VAD in pediatric patients with heart failure. This study ...

Hypophosphatemia as a Predictor in Surgical Resuscitation Sepsis

Retrospective study in the surgical intensive care unit of the Brest Teaching Hospital (France) during a 6-months period (January 2015 -May 2015) to study the independent association betwe...

Companies [236 Associated Companies listed on BioPortfolio]

IATI-Biomed 2015

For the 14th consecutive year, IATI-Biomed is the largest and leading meeting place for healthcare professionals from Israel with international colleagues and partners. As such...

IATI-BioMed Conference

IATI, run by CEO Karin Mayer Rubinstein is the largest umbrella organization representing the hi-tech and life sciences industries. With over 450 members, its mission is to streng...

IATI-BioMed Israel Conference 2013

Mercury Biomed

Based in Cleveland, Ohio, Mercury Biomed, LLC is commercializing its proprietary Smart Temperature Management System™ technology, a breakthrough non-invasive and holistic app...

Biomed Pharmaceuticals

The Company is a leading pharmacy provider of intravenous and injectable medications for patients with chronic disorders. Biomed treats a variety of immune deficient and autoimmun...

More Information about "IATI-Biomed 2015" on BioPortfolio

We have published hundreds of IATI-Biomed 2015 news stories on BioPortfolio along with dozens of IATI-Biomed 2015 Clinical Trials and PubMed Articles about IATI-Biomed 2015 for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of IATI-Biomed 2015 Companies in our database. You can also find out about relevant IATI-Biomed 2015 Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record